Iconovo AB develops, manufactures and supplies inhalation products. It offers inhalers for medications used in the treatment of asthma and respiratory disorders. The firm's products include ICOres, ICOcap, ICOpre, and ICOone. Iconovo was founded in 2013 and is headquartered in Lund, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company